Observing and monitoring behaviors early can set kids up for long-term well-being
Navigating early developmental care for newborns and toddlers can be daunting for parents, but catching challenges early can ...
Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher today
These shares are avoiding the market weakness on Thursday. But why? The post Why Core Lithium, Healius, Neuren, and Reject ...
Neuren targets infant brain injury with new NNZ-2591 program
Neuren Pharmaceuticals (ASX:NEU) has announced it will develop its drug candidate NNZ-2591 to treat hypoxic-ischemic ...
Capital Brief5d
Neuren Pharma shares lift on new drug development
Neuren Pharmaceuticals has announced it will develop a new drug to treat a type of life-threatening brain injury in infants, ...
2 ASX 200 biotech stocks announcing big news today
The ASX 200 biotech stock notes that HIE is a devastating type of brain injury caused when a baby's brain does not receive ...
Newborn baby 'failed' by hospital staff - parents
A couple whose newborn baby was starved of oxygen during labour have told a coroner's court she was "failed by those looking ...
Autism Spectrum Disorder: Diffusion Weighted MRI To Rule Out Hypoxic Injuries
Dr. Greg Vigna Study links prenatal hypoxia to larger third ventricle volumes and sensory issues in ASD, emphasizing early diagnosis and in ...
SciELO15d
The impact of clinical seizures and adverse brain MRI patterns in neonates with hypoxic-ischemic encephalopathy and abnormal neurodevelopment
Introduction This study aimed to investigate the associations among seizures, clinical characteristics, and brain injury on Magnetic Resonance Imaging (MRI) in infants with Hypoxic Ischemic ...
rheumatologyadvisor22d
CDC IDs Trends in Pediatric Flu Deaths With Influenza-Linked Encephalopathy
Based on preliminary data for 2024 to 2025, 13% of pediatric deaths had influenza-associated encephalopathy, encephalitis. HealthDay News — During the 2010-2011 to 2024-2025 influenza seasons, 9 ...
Medical Xpress26d
FDA approves TNKase for acute ischemic stroke
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...